Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (131-140 of 511) with videos related to

Pageof 52
Sort By:
Plos One|February 17, 2022
Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensationPhilipp Stoffers, Sabrina Guckenbiehl, Martin Walter Welker, et al.
Visceral Medicine|October 23, 2018
Acute-on-Chronic Liver FailureChristian M Lange, Wolf Otto Bechstein, Thomas Berg, et al.
Vaccines|September 28, 2023
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control SubjectsRichard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, et al.
Geroscience|December 24, 2025
MASLD in the oldest-old: lack of association with cognition or functional autonomy and poor predictive utility of the hepatic steatosis indexMaximilian Joseph Brol, Martin Groth, Frank Erhard Uschner, et al.
Scientific Reports|June 12, 2026
Performance of GPT-based large language models in hepatocellular carcinoma stratification: liver function assessment, BCLC staging, and treatment recommendationsMax Masthoff, Amelie Zipser, Michael Praktiknjo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2008
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot studyBeate Appenrodt, Andrea Wolf, Frank Grünhage, et al.
Gut|February 15, 2011
Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoactionLukas Moleda, Jonel Trebicka, Peter Dietrich, et al.
European Journal of Gastroenterology & Hepatology|November 5, 2010
Is detection of bacterial DNA in ascitic fluid of clinical relevance?Beate Appenrodt, Lutz E Lehmann, Lydia Thyssen, et al.
Plos One|July 29, 2014
The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPSChristian Jansen, Hannah Eischeid, Jan Goertzen, et al.
Metabolic Brain Disease|November 19, 2022
Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?Wim Laleman, Michael Praktiknjo, Mette Munk Lauridsen, et al.
Pageof 52

Showing results (131-140 of 511) with videos related to

Sort By:
Pageof 52
Plos One|February 17, 2022
Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensationPhilipp Stoffers, Sabrina Guckenbiehl, Martin Walter Welker, et al.
Visceral Medicine|October 23, 2018
Acute-on-Chronic Liver FailureChristian M Lange, Wolf Otto Bechstein, Thomas Berg, et al.
Vaccines|September 28, 2023
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control SubjectsRichard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, et al.
Geroscience|December 24, 2025
MASLD in the oldest-old: lack of association with cognition or functional autonomy and poor predictive utility of the hepatic steatosis indexMaximilian Joseph Brol, Martin Groth, Frank Erhard Uschner, et al.
Scientific Reports|June 12, 2026
Performance of GPT-based large language models in hepatocellular carcinoma stratification: liver function assessment, BCLC staging, and treatment recommendationsMax Masthoff, Amelie Zipser, Michael Praktiknjo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2008
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot studyBeate Appenrodt, Andrea Wolf, Frank Grünhage, et al.
Gut|February 15, 2011
Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoactionLukas Moleda, Jonel Trebicka, Peter Dietrich, et al.
European Journal of Gastroenterology & Hepatology|November 5, 2010
Is detection of bacterial DNA in ascitic fluid of clinical relevance?Beate Appenrodt, Lutz E Lehmann, Lydia Thyssen, et al.
Plos One|July 29, 2014
The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPSChristian Jansen, Hannah Eischeid, Jan Goertzen, et al.
Metabolic Brain Disease|November 19, 2022
Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?Wim Laleman, Michael Praktiknjo, Mette Munk Lauridsen, et al.
Pageof 52